Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-०.२०%
१,१०८.२३
-२.२४
-०.२०%
—१,११०.४७१,१०७.७५१,१११.३४१,०९३.८१——
SIXC
Communications
SIXC
Communications
SIXC
+०.२६%
६०५.६३
+१.५६
+०.२६%
—६०४.०७६०४.०७६०६.०४६००.९१——
SIXE
Energy
SIXE
Energy
SIXE
+०.७०%
१,२०९.९५
+८.४६
+०.७०%
—१,२०१.४९१,२०५.९२१,२१५.३११,२०१.०२——
SIXI
Industrials
SIXI
Industrials
SIXI
-०.४०%
१,७५८.२३
-७.०७
-०.४०%
—१,७६५.३०१,७६४.०३१,७६४.०३१,७३६.४०——
SIXM
Financials
SIXM
Financials
SIXM
+०.७२%
६३४.९४
+४.५२
+०.७२%
—६३०.४२६३०.३४६३६.६९६२६.०३——
SIXR
Staples
SIXR
Staples
SIXR
+१.३०%
८५२.३७
+१०.९२
+१.३०%
—८४१.४५८४३.६०८५८.११८४०.११——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+०.०१%
२१८.८५
+०.०२०
+०.०१%
—२१८.८३२१८.८३२१९.३२२१७.३३——
SIXT
Technology
SIXT
Technology
SIXT
-१.५०%
३,५२८.४९
-५३.७४
-१.५०%
—३,५८२.२३३,५५०.६०३,५६२.६२३,४४७.७८——
SIXU
Utilities
SIXU
Utilities
SIXU
+०.१०%
९१४.८२
+०.९३
+०.१०%
—९१३.८९९१२.७५९१८.१२९०६.६७——
SIXV
Health care
SIXV
Health care
SIXV
+१.९३%
१,४७२.२७
+२७.९४
+१.९३%
—१,४४४.३३१,४४६.८७१,४८०.७४१,४४६.३०——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-०.९३%
२,३९०.६१
-२२.३५
-०.९३%
—२,४१२.९६२,४०३.९९२,४११.४१२,३७३.९०——
Q4 2026 earnings • released • EPS miss -२९.०७% • Revenue miss -२.५७%
See results
CIPLA:NSE
Cipla Ltd
₹ १,३२७.२०
+२.७०%
(+३४.९०) 1D
मे १३, १५:२१:४९ GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for CIPLA...
Open
₹ १,२७९.१०
High
₹ १,३५६.६०
Low
₹ १,२७४.७०
Mkt. cap
१०.७२ खरब
Avg. vol.
१७.२६ लाख
Volume
५८.८८ लाख
Dividend
०.९८%
Quarterly dividend
₹ ३.२५
Ex dividend date
२०२४ अगस्ट २
P/E ratio
२३.५९
52-wk high
₹ १,६७३.००
52-wk low
₹ १,१६५.७०
EPS
₹ ५६.२६
Shares outstanding
८०.५७ करोड
No. of employees
३० हजार
News stories
From sources across the web
TradingView
TradingView
·
१ घण्टा पहिले
Cipla Q4 profit misses estimates as US market competition weighs
Profile
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
About Cipla Ltd
CEOUmang Vohra
Employees३०.३ हजार
Founded१९३५
Headquartersमुम्बई, महाराष्ट्र, भारत
Sector-
Websitecipla.com
Last report
Just released
Today, १२:३०
Fiscal Period
Q4 2026
EPS / Est. (INR)
₹ ६.८६ / ₹ ९.६७
-२९.०७%miss
Revenue / Est. (INR)
६५.४१ अरब / ६७.१४ अरब
-२.५७%miss
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
२०२५ मार्च
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
Revenue
६७.२० अरब
६८.३७ अरब
७४.४७ अरब
६९.६३ अरब
Cost of goods sold
२४.३५ अरब
२१.७१ अरब
२४.९८ अरब
२६.३२ अरब
Cost of revenue
२४.३५ अरब
२१.७१ अरब
२४.९८ अरब
२६.३२ अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२५.०७ अरब
१३.१२ अरब
१३.१५ अरब
१३.२५ अरब
Operating expense
२९.४७ अरब
३१.४१ अरब
३३.५२ अरब
३३.५४ अरब
Total operating expenses
५३.८३ अरब
५३.१२ अरब
५८.५० अरब
५९.८६ अरब
Operating income
१३.३७ अरब
१५.२५ अरब
१५.९८ अरब
९.७७ अरब
Other non operating income
-२.८९ अरब
२.५९ अरब
२.६९ अरब
२.०६ अरब
EBT including unusual items
१४.९३ अरब
१७.६९ अरब
१८.५४ अरब
८.९३ अरब
EBT excluding unusual items
१२.९६ अरब
१७.६९ अरब
१८.५४ अरब
११.६९ अरब
Income tax expense
२.७९ अरब
४.७८ अरब
५.०० अरब
२.१९ अरब
Effective tax rate
१८.७०%
२७.०१%
२७.००%
२४.४८%
Other operating expenses
२.४० अरब
१५.७६ अरब
१७.४० अरब
१७.५१ अरब
Net income
१२.२२ अरब
१२.९८ अरब
१३.५१ अरब
६.७६ अरब
Net profit margin
१८.१८%
१८.९८%
१८.१४%
९.७१%
Earnings per share
१५.१२
१६.०६
१६.७२
१०.९४
Interest and investment income
२.६८ अरब
-
-
-
Interest expense
-
-१४.०५ करोड
-१३.१८ करोड
-१४.०३ करोड
Net interest expenses
२.६८ अरब
-१४.०५ करोड
-१३.१८ करोड
-१४.०३ करोड
Depreciation and amortization charges
२.०१ अरब
२.५३ अरब
२.९७ अरब
२.७८ अरब
EBITDA
१५.६० अरब
१७.४९ अरब
१८.७३ अरब
१२.०० अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer